PTX 0.00% 4.0¢ prescient therapeutics limited

Ann: PTX-200 Breast Cancer Trial Progresses, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,097 Posts.
    lightbulb Created with Sketch. 133
    On a completely different bio forum we've recently been discussing whether drugs have to go through the full PhI-II-III process to get to market, and one example that came up was this:

    http://www.cancertherapyadvisor.com...ilzomib-combination-treatment/article/466936/

    I have to read the background and come to grips with the whole story, but am interested in other posters thoughts as we move towards Ph II. (credit to HC user DiamondJoe who provided the link with some background).
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.0¢ 4.0¢ $1K 25K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 6756 1
View Market Depth
Last trade - 10.06am 20/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.